Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004278 |
---|---|
Receipt number | R000004308 |
Scientific Title | A feasibility study of neoadjuvant therapy with cisplatin, pemetrexed, and bevacizumab (Avastin®) in patients with non-squamous non small cell lung cancer (NAVAL study) |
Date of disclosure of the study information | 2010/10/01 |
Last modified on | 2019/07/29 12:09:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/28 17:21:19 | ||
2 | Update | 2015/10/31 11:30:40 | Email Last name of contact person Last name of contact person TEL Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2017/04/04 16:25:52 | Name of primary person or sponsor Organization |
|
4 | Update | 2017/04/04 16:26:50 | Recruitment status |
|
5 | Update | 2019/07/29 12:02:40 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2019/07/29 12:04:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address TEL Organization Organization Address Address Tel |
|
7 | Update | 2019/07/29 12:09:52 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |